ALK’s Grazax fails to prevent asthma, but reduces symptoms – PharmaTimes

ALK's Grazax fails to prevent asthma, but reduces symptoms
PharmaTimes
On the plus side, treatment with Grazax did have a positive effect on the children's asthma symptoms and use of asthma medication; the odds ratio for these at the end of the five-year evaluation period was 0.66 in favour of ALK's therapy, the firm said.